Association of Persistent, Incident, and Remittent Proteinuria With Stroke Risk in Patients With Diabetes Mellitus or Prediabetes Mellitus
Wang A, Jiang R, Su Z, et al.
J Am Heart Assoc. Pub. online 12 October 2017
Leggi
Breaking news
Effect of Population Screening for Type 2 Diabetes And Cardiovascular Risk Factors On Mortality Rate And Cardiovascular Events: A Controlled Trial Among 1,912,392 Danish Adults
Simmons RK, Griffin SJ, Witte DR, et al.
Diabetologia. 2017;60(11):2183-91
Leggi
Omega-6 Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of Individual-Level Data For 39 740 Adults From 20 Prospective Cohort Studies
Wu JHY, Marklund M, Imamura F, et al.
The Lancet Diabetes & Endocrinology. Pub. online 11 October 2017
Leggi
Linoleic Acid and Risk of Type 2 Diabetes
Riccardi G
The Lancet Diabetes & Endocrinology. Pub. online 11 October 2017
Leggi
Effect of Screening for Type 2 Diabetes On Risk Of Cardiovascular Disease And Mortality: A Controlled Trial Among 139,075 Individuals Diagnosed With Diabetes In Denmark Between 2001 And 2009
Simmons RK, Griffin SJ, Lauritzen T, et al.
Diabetologia. 2017;60(11):2192-9
Leggi
Inpatient Glucose Values: Determining the Nondiabetic Range and Use in Identifying Patients at High Risk for Diabetes
Rhee MK, Safo SE, Jackson SLM, et al.
The American Journal of Medicine. Pub. online: October 6, 2017
Leggi
Challenges in Choosing a Medication for Type 2 Diabetes
Rodríguez-Gutiérrez R, Salcido-Montenegro A, Elizondo-Plazas A, et al.
Diabetes Technol Ther. Pub. online September 2017
Leggi
Exenatide Once Weekly Versus Placebo in Parkinson’s Disease: A Randomised, Double-Blind, Placebo-Controlled Trial
Athauda D, Maclagan K, Skene SS, et al.
The Lancet. 2017;390(10103):1664-75
Leggi
Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus
Ernande L, Audureau E, Jellis CL, et al.
J Am Coll Cardiol 2017;70(14):1704-16
Leggi
Insulin Signalling: New Target for Parkinson’s Treatments?
Poewe W, Seppi K
The Lancet. 2017;390(10103):1628-30
Leggi